Giant testicular tumor. Clinical and hormonal considerations

JM Tovar Rodríguez; Bañuelos Ávila L; Chávez Zúñiga I; VM Vargas Hernández

2006, Number 6

<< Back Next >>

Rev Mex Urol 2006; 66 (6)

Giant testicular tumor. Clinical and hormonal considerations

Tovar RJM, Bañuelos AL, Chávez ZI, Vargas HVM

Full text

How to cite this article

Language: Spanish
References: 3
Page: 310-313
PDF size: 170.22 Kb.

ABSTRACT

We report the case of a patient 30 years old with testicular cancer (seminoma) of 2,350 g of 4 months in progress. We determine luteinizing hormone (LH), follicle stimulate hormone (FSH), without change before and after orchiectomy, testosterone total and free decrease at 50% after surgery, this is because the concentration of human Gonadotropin Chorionic (hCG) was high whereby stimulate the leydig cell to synthesize testosterone.
We think important to determine what factor or substance flattering the growth of this type of tumor.

REFERENCES

Chaganti RSK, Houldsworth J. Genetics and Biology of Human Male Germ Cell tumors. Cancer Res. 2000; 60:1475-1482.
Dearnaley DP, Huddart RA, Horwich A. Managing testicular cancer. BMJ. 2000;322:1583-1588.
Walsh PC, Retik AB, Stamey AB, Vaughan ED, eds. Neoplasms of testis chap. 30 Richie JP. In Campbell’s Urology, Philadelphia WB Saunders. 1992; p. 1222-1263.